Pantherics

About:

Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.

Website: https://pantherics.com/

Top Investors: National Institutes of Health, UWM Research Foundation

Description:

Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.

Total Funding Amount:

$519000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Milwaukee, Wisconsin, United States

Founded Date:

2019-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-08-11

IPO Status:

Private

Industries: